The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster. BETHESDA ...

Roya Amini-Naieni CEO and Co-Founder For decades, the promise of lab automation has remained out of reach for many scientists due to high costs and complex integrations.

Emotional eating and body dissatisfaction mediate links between BMI changes and mental health. These psychosocial factors ...

The European Union's border protection agency says it is investigating multiple alleged human rights violations by Greece in ...

The new laboratory space will increase the company’s pace of discovery for potential therapeutics including multiple chronic disease indications and will enhance the development of treatment ...

Researchers at the University of South Australia (UniSA) are employing quantum technology to develop a unique laparoscopic ...

WILMINGTON, DE / ACCESS Newswire / April 8, 2025 / MedScale is an e-commerce agency specializing in helping medical professionals build, launch, and scale private-label supplement brands on Amazon, ...

Research details hyaluronic acid's properties through SEC-MALS and differential viscometry, highlighting its molecular weight and conformational behavior.

“We’re advancing REC-3565, a potential best-in-class MALT1 inhibitor, to improve outcomes for patients with B-cell malignancies with limited treatment options,” said David Mauro, Chief Medical Officer ...

The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug developmen ...

DelveInsight's "TIBSOVO Market Size, Forecast, and Market Insight Report" highlights the details around TIBSOVO, the first and only targeted therapy approved for patients with previously treated ...